North America Contract Research Organization (CRO) Market Analysis and Forecast by Size, Share, Growth, Trends 2031
North America Contract Research Organization (CRO) Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type (Early Phase Development Services, Clinical Research Services, Laboratory Services, and Post-Approval Services), Product Type (Cell and Gene Therapy, Biosimilars, Antibody Drug Conjugates, and Others), Type (In-house and Outsource), Application (Oncology, Neurology, Cardiology, Infectious Diseases, Metabolic Disorder, Nephrology, Respiratory, Dermatology, Ophthalmology, Hematology, and Others), and End User (Pharmaceutical and Biotech Companies, Medical Device Companies, Academic and Research Institutes, and Others)
- Report Date : Nov 2025
- Report Code : TIPRE00004300
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 181
The North America Contract Research Organization (CRO) Market size is expected to reach US$ 42,712.4 Million by 2031 from US$ 24,846.6 Million in 2024. The market is estimated to record a CAGR of 8.0% from 2024 to 2031.
Executive Summary and North America Contract Research Organization (CRO) Market Analysis:The contract research organization market in North America is segmented into the US, Canada, and Mexico. The US holds the largest market share, followed by Canada. The growth in North America is characterized by growing demand for contract research organizations by the healthcare market players, growing support from the government to provide cost-effective healthcare service, increasing strategic developments by the contract research organization players to enhance services, and a growing healthcare industry that demands frameworks and guidelines based on the real-world data for their business models
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
North America Contract Research Organization (CRO) Market: Strategic Insights
| Market Size Value in | US$ 16.3 Bn in 2017 |
| Market Size Value by | US$ 30.7 Billion by 2025 |
| Growth rate | CAGR of 8.4% from 2018-2025 |
| Forecast Period | 2018-2025 |
| Base Year | 2018 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- By Service Type, the North America Contract Research Organization (CRO) Market is segmented into Early Phase Development Services, Clinical Research Services, Laboratory Services, and Post-Approval Services. Clinical Research Services held the largest share of the market in 2024.
- By Product Type, the North America Contract Research Organization (CRO) Market is segmented into Cell and Gene Therapy, Biosimilars, Antibody Drug Conjugates, and Others. Biosimilars held the largest share of the market in 2024.
- By Type, the North America Contract Research Organization (CRO) Market is segmented into In-house and Outsource. Outsource held the largest share of the market in 2024.
- By Application, the North America Contract Research Organization (CRO) Market is segmented into Oncology, Neurology, Cardiology, Infectious Diseases, Metabolic Disorder, Nephrology, Respiratory, Dermatology, Ophthalmology, Hematology, and Others. Oncology held the largest share of the market in 2024.
- By End User, the North America Contract Research Organization (CRO) Market is segmented into Pharmaceutical and Biotech Companies, Medical Device Companies, Academic and Research Institutes, and Others. Pharmaceutical and Biotech Companies held the largest share of the market in 2024.
The Contract Research Organization (CRO) industry is growing strongly across the globe, owing to the rising outsourcing of research and development (R&D) operations in pharmaceutical, biotechnology, and medical device firms. With the healthcare sector becoming increasingly competitive and innovation-driven, firms are under tremendous pressure to speed up drug discovery. Contracting R&D to CROs enables companies to access their specialized expertise, sophisticated infrastructure, and global connectivity without significant investments. CROs offer full-service solutions, from preclinical research to clinical trials, regulatory affairs, and post-marketing surveillance, and thus help sponsors concentrate on their core competencies.
Discovery CROs are forming long-term strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other CROs. These collaborations can involve co-developing drugs, joint ventures, or preferred provider agreements, allowing both parties to leverage each other's strengths. Such partnerships can significantly reduce the time required to bring a drug to market, accelerating the process by months compared to traditional outsourcing. In the US, it typically takes 10 to 15 years and over US$2.5 billion to develop a single drug, with most costs arising from the discovery and development phases. By sharing expertise, resources, and technologies, these collaborations foster innovation, help mitigate risks, and distribute research costs. Therefore, the market is well-positioned for continued growth due to rising dependence on R&D outsourcing to achieve efficiency, save costs, and get life-saving drugs to patients more quickly.
North America Contract Research Organization (CRO) Market Country InsightsBy country, the North America Contract Research Organization (CRO) Market is segmented into the United States, Canada, and Mexico. The United States held the largest share in 2024.
The US is the largest market for contract research organizations and is estimated to continue its dominancy owing to the presence of leading contract research organizations, a well-established healthcare industry that provides a broader scope for contract research organizations, and a growing shift toward outsourcing R&D and clinical trial services. Contract research organizations are crucial to the biotechnology, pharmaceutical, and medical device industries owing to their offering of outsourced research services that help accelerate the typically prolonged and complicated drug development process. Due to the need for quicker drug development and technical developments, the landscape for contract research organizations in the US is evolving quickly. The regulatory environment heavily impacts the operation of contract research organizations. Initiatives such as real-time assessment, which permits simultaneous data assessment during clinical trials, have been established by the US FDA. Contract research organizations manage and evaluate data in real time related to this change. There is a growing number of clinical trials with increasing investments in research and development in the country. According to an article published in the United States National Library of Medicine in May 2023, 437,533 clinical trials were registered in 221 countries in 2023, an increase from 399,499 in 2022, among which 140,492 (31%) were registered in the US. Contract research organizations help lower the risks of trial delays and regulatory obstacles by assisting pharmaceutical businesses in navigating this environment.
Therefore, the above-mentioned benefits offered by contract research organizations are contributing to the growth of the market in the US
North America Contract Research Organization (CRO) Market Company ProfilesSome of the key players operating in the market include Parexel International Corp, IQVIA Holdings Inc, Syneos Health Inc, Medpace Holdings Inc, Thermo Fisher Scientific (PPD Inc), ProPharma Group, Precision Medicine Group, LLC., O4 Research Ltd, Julius Clinical, Siron Clinical, Clinmark sp. z o.o., Pharmaxi LLC, Smerud Medical Research Group, AURIGON GMBH.
These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.
North America Contract Research Organization (CRO) Market Research MethodologyThe following methodology has been followed for the collection and analysis of data presented in this report:
Secondary Research
The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
Company websites,
annual reports, financial statements, broker analyses, and investor presentationsIndustry trade journals
and other relevant publicationsGovernment documents,
statistical databases, and market reportsNews articles,
press releases, and webcasts specific to companies operating in the market
Note:
All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.Primary Research
The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:
- Validate and refine findings from secondary research
- Enhance the expertise and market understanding of the analysis team
- Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects
Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:
Industry stakeholders:
Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales ManagersExternal experts:
Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, End User and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. Contract Research Organization (CRO) Market Landscape
4.1 PEST Analysis
5. North America Contract Research Organization (CRO) Market - Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. Contract Research Organization (CRO) Market - North America Market Analysis
6.1 North America Contract Research Organization (CRO) Market Revenue (US$ Million), 2024 - 2031
6.2 North America Contract Research Organization (CRO) Market Forecast and Analysis
7. North America Contract Research Organization (CRO) Market Revenue Analysis - by Service Type
7.1 Early Phase Development Services
7.1.1 Overview
7.1.2 Early Phase Development Services: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Clinical Research Services
7.2.1 Overview
7.2.2 Clinical Research Services: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Laboratory Services
7.3.1 Overview
7.3.2 Laboratory Services: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Post-Approval Services
7.4.1 Overview
7.4.2 Post-Approval Services: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. North America Contract Research Organization (CRO) Market Revenue Analysis - by Product Type
8.1 Cell and Gene Therapy
8.1.1 Overview
8.1.2 Cell and Gene Therapy: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Biosimilars
8.2.1 Overview
8.2.2 Biosimilars: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Antibody Drug Conjugates
8.3.1 Overview
8.3.2 Antibody Drug Conjugates: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4 Others
8.4.1 Overview
8.4.2 Others: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. North America Contract Research Organization (CRO) Market Revenue Analysis - by Type
9.1 In-house
9.1.1 Overview
9.1.2 In-house: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Outsource
9.2.1 Overview
9.2.2 Outsource: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. North America Contract Research Organization (CRO) Market Revenue Analysis - by Application
10.1 Oncology
10.1.1 Overview
10.1.2 Oncology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Neurology
10.2.1 Overview
10.2.2 Neurology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Cardiology
10.3.1 Overview
10.3.2 Cardiology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.4 Infectious Diseases
10.4.1 Overview
10.4.2 Infectious Diseases: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.5 Metabolic Disorder
10.5.1 Overview
10.5.2 Metabolic Disorder: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.6 Nephrology
10.6.1 Overview
10.6.2 Nephrology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.7 Respiratory
10.7.1 Overview
10.7.2 Respiratory: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.8 Dermatology
10.8.1 Overview
10.8.2 Dermatology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.9 Ophthalmology
10.9.1 Overview
10.9.2 Ophthalmology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.10 Hematology
10.10.1 Overview
10.10.2 Hematology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.11 Others
10.11.1 Overview
10.11.2 Others: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. North America Contract Research Organization (CRO) Market Revenue Analysis - by End User
11.1 Pharmaceutical and Biotech Companies
11.1.1 Overview
11.1.2 Pharmaceutical and Biotech Companies: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2 Medical Device Companies
11.2.1 Overview
11.2.2 Medical Device Companies: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.3 Academic and Research Institutes
11.3.1 Overview
11.3.2 Academic and Research Institutes: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.4 Others
11.4.1 Overview
11.4.2 Others: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12. North America Contract Research Organization (CRO) Market - Country Analysis
12.1 North America
12.1.1 North America Contract Research Organization (CRO) Market Revenue and Forecast and Analysis - by Country
12.1.1.1 North America Contract Research Organization (CRO) Market Revenue and Forecast and Analysis - by Country
12.1.2.2 United States: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.1.2.2.1 United States: North America Contract Research Organization (CRO) Market Share - by Service Type
12.1.2.2.2 United States: North America Contract Research Organization (CRO) Market Share - by Product Type
12.1.2.2.3 United States: North America Contract Research Organization (CRO) Market Share - by Type
12.1.2.2.4 United States: North America Contract Research Organization (CRO) Market Share - by Application
12.1.2.2.5 United States: North America Contract Research Organization (CRO) Market Share - by End User
12.2.3.3 Canada: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.2.3.3.1 Canada: North America Contract Research Organization (CRO) Market Share - by Service Type
12.2.3.3.2 Canada: North America Contract Research Organization (CRO) Market Share - by Product Type
12.2.3.3.3 Canada: North America Contract Research Organization (CRO) Market Share - by Type
12.2.3.3.4 Canada: North America Contract Research Organization (CRO) Market Share - by Application
12.2.3.3.5 Canada: North America Contract Research Organization (CRO) Market Share - by End User
12.3.4.4 Mexico: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.3.4.4.1 Mexico: North America Contract Research Organization (CRO) Market Share - by Service Type
12.3.4.4.2 Mexico: North America Contract Research Organization (CRO) Market Share - by Product Type
12.3.4.4.3 Mexico: North America Contract Research Organization (CRO) Market Share - by Type
12.3.4.4.4 Mexico: North America Contract Research Organization (CRO) Market Share - by Application
12.3.4.4.5 Mexico: North America Contract Research Organization (CRO) Market Share - by End User
13 Competitive Landscape
13.1 Heat Map Analysis by Key Players
13.2 Company Positioning & Concentration
14 Industry Landscape
14.1 Overview
14.2 New Product Development
14.3 Merger and Acquisition
14.4 Other Strategic Developments
15 COMPANY PROFILES
15.1 Parexel International Corp
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 IQVIA Holdings Inc
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Syneos Health Inc
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 Medpace Holdings Inc
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Thermo Fisher Scientific (PPD Inc)
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 ProPharma Group
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Precision Medicine Group, LLC.
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 O4 Research Ltd
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 Julius Clinical
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 Siron Clinical
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Products and Services
15.10.4 Financial Overview
15.10.5 SWOT Analysis
15.10.6 Key Developments
15.11 Clinmark sp. z o.o.
15.11.1 Key Facts
15.11.2 Business Description
15.11.3 Products and Services
15.11.4 Financial Overview
15.11.5 SWOT Analysis
15.11.6 Key Developments
15.12 Pharmaxi LLC
15.12.1 Key Facts
15.12.2 Business Description
15.12.3 Products and Services
15.12.4 Financial Overview
15.12.5 SWOT Analysis
15.12.6 Key Developments
15.13 Smerud Medical Research Group
15.13.1 Key Facts
15.13.2 Business Description
15.13.3 Products and Services
15.13.4 Financial Overview
15.13.5 SWOT Analysis
15.13.6 Key Developments
15.14 AURIGON GMBH
15.14.1 Key Facts
15.14.2 Business Description
15.14.3 Products and Services
15.14.4 Financial Overview
15.14.5 SWOT Analysis
15.14.6 Key Developments
16. Appendix
16.1 About The Insight Partners
List of Tables
Table 1. North America Contract Research Organization (CRO) Market Segmentation
Table 3. North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
Table 5. North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
Table 6. North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 7. North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 8. North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 9. North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 10. United States: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
Table 11. United States: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
Table 12. United States: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 13. United States: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 14. United States: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 15. Canada: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
Table 16. Canada: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
Table 17. Canada: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 18. Canada: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 19. Canada: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 20. Mexico: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
Table 21. Mexico: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
Table 22. Mexico: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 23. Mexico: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 24. Mexico: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 25. Heat Map Analysis by Key Players
List of Figures
Figure 1. North America Contract Research Organization (CRO) Market Segmentation - Country
Figure 1. PEST Analysis
Figure 4. North America Contract Research Organization (CRO) Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. North America Contract Research Organization (CRO) Market Revenue (US$ Million), 2024 - 2031
Figure 7. North America Contract Research Organization (CRO) Market Share (%) - by Service Type, 2024 and 2031
Figure 8. Early Phase Development Services: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Clinical Research Services: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Laboratory Services: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Post-Approval Services: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. North America Contract Research Organization (CRO) Market Share (%) - by Product Type, 2024 and 2031
Figure 13. Cell and Gene Therapy: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Biosimilars: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Antibody Drug Conjugates: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Others: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. North America Contract Research Organization (CRO) Market Share (%) - by Type, 2024 and 2031
Figure 18. In-house: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Outsource: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. North America Contract Research Organization (CRO) Market Share (%) - by Application, 2024 and 2031
Figure 21. Oncology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Neurology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Cardiology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. Infectious Diseases: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Metabolic Disorder: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. Nephrology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Respiratory: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Dermatology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 29. Ophthalmology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 30. Hematology: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 31. Others: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. North America Contract Research Organization (CRO) Market Share (%) - by End User, 2024 and 2031
Figure 33. Pharmaceutical and Biotech Companies: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 34. Medical Device Companies: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 35. Academic and Research Institutes: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 36. Others: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 37. North America Contract Research Organization (CRO) Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 38. United States: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 39. Canada: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 40. Mexico: North America Contract Research Organization (CRO) Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 41. Company Positioning & Concentration
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For